1.1 	A bill for an act
1.2 	relating to higher education; appropriating money for amyotrophic lateral sclerosis 
1.3 	research; requiring a report.
1.4 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.5 	Section 1. APPROPRIATION.
 1.6 	(a) $20,000,000 in fiscal year 2023 is appropriated from the general fund to the 
1.7 	commissioner of the Office of Higher Education to award competitive grants to applicants 
1.8 	for research into amyotrophic lateral sclerosis (ALS). The commissioner may work with 
1.9 	the Minnesota Department of Health to administer the grant program, including application 
1.10 	review and grant recipient selection. Not more than $150,000 per fiscal year, beginning in 
1.11 	fiscal year 2023 to fiscal year 2026, may be used by the commissioner to administer the 
1.12 	grant program.
1.13 	(b) Grants shall be awarded to support clinical and translational research related to ALS. 
1.14 	Research topics may include but are not limited to environmental factors, disease 
1.15 	mechanisms, disease models, biomarkers, drug development, clinical studies, precision 
1.16 	medicine, medical devices, assistive technology, and cognitive studies.
1.17 	(c) Eligible applicants for the grants are research facilities, universities, and health 
1.18 	systems located in Minnesota. Applicants must submit proposals to the commissioner in 
1.19 	the time, form, and manner established by the commissioner.
1.20 	(d) Beginning January 15, 2023, and annually thereafter until January 15, 2027, the 
1.21 	commissioner shall submit a report to the legislature specifying the applicants receiving 
2.1 	grants under this section, the amount of each grant, the purposes for which the grant funds 
2.2 	were used, and the amount of the appropriation that is unexpended.
2.3 	(e) This is a onetime appropriation. Notwithstanding Minnesota Statutes, section 16A.28, 
2.4 	unencumbered balances under this section do not cancel until July 1, 2026.